Sprint Bioscience AB (publ) (FRA:5JA1)
Germany flag Germany · Delayed Price · Currency is EUR
0.1290
+0.0060 (4.88%)
At close: Dec 4, 2025

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Small Molecules Drug
50.49M
Log In
Log In
Log In
Log In
Upgrade
Small Molecules Drug Growth
60725.30%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
50.45M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
144028.57%
Log In
Log In
Log In
Log In
Upgrade
Sweden
41.00K
Log In
Log In
Log In
Log In
Upgrade
Sweden Growth
-14.58%
Log In
Log In
Log In
Log In
Upgrade
Asia
-
Log In
Log In
Log In
Log In
Upgrade
Asia Growth
-
Log In
Log In
Log In
Log In
Upgrade